Roche revealed promising results from two pivotal Phase III trials, MEERKAT and SANDCAT, assessing vamikibart, an investigational non-steroidal medication for uveitic macular edema (UME). UME is attributable to inflammation and an accumulation...
Novartis announced that Cosentyx met its primary endpoint and all secondary endpoints in the Phase III REPLENISH study, a significant milestone in the treatment of polymyalgia rheumatica. At Week 52, Cosentyx demonstrated statistically...
Xavier School of Management, Jamshedpur, was the venue of a distinguished leadership session with Jacob Jacob, Group Chief Human Resources Officer of Aster DM Healthcare, Dubai, as part of the Aster NextGen Management
Superhealth, the first hospital network in India to offer zero wait times and zero commissions, has today announced a significant strategic partnership with the global imaging innovator, United Imaging Healthcare
Novo Nordisk's primary investor has taken steps to gain control of the pharmaceutical company's board, pledging to concentrate more on the crucial U.S. market in order to rejuvenate sales of the highly successful weight-loss medication Wegovy, follow
In patients with advanced endometrial cancer, five-year data from the Phase 3 KEYNOTE-775/Study 309 trial revealed a durable survival benefit for KEYTRUDA plus LENVIMA compared to chemotherapy, according to Merck, which is known as MSD outside of the
Pfizer Inc. publicly released updated outcomes from the Phase 2 PHAROS trial examining Braftovi (encorafenib) + Mektovi (binimetinib) in adult subjects with metastatic non-small cell lung cancer (mNSCLC) harboring the BRAF V600E mutation...
The Union Ministry of Health and Family Welfare has suggested a significant modification of the Drugs Rules 1945, which would require Quick Response codes (QR)on labels of all medicines - vaccines, antimicrobials, anticancer, narcotic and...
Recently published data from the FLUNITY-HD Study in The Lancet illustrates that Efluelda provided significantly more protection against hospitalizations than standard-dose influenza vaccines in adults aged 65 and older...
.jpg "WHO Warns India Still has Work to Curb Toxic Cough Syrups")
India continues to be a difficult place regarding the total elimination of toxic cough syrup sales, says a representative of the World Health Organization (WHO). The news comes after 24 children died, at the very least, after taking the Coldrif co...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")